Abstract:Background Chitosan has been shown to possess useful properties such as non-toxicity, high biocompatibility and non-antigenicity that offer advantages for vaccine delivery systems. In this study, we prepared novel chitosan derivative nanoparticles as DNA vaccine carriers and the potential and mechanism of the DNA-nanoparticle complexes in inducing augmented immune responses were explored.Methods The pVAX(HBc)DNA-nanoparticle complexes as vaccine delivery systems were studied in several aspects: the protection against DNase I degradation was measured by an in vitro inhibition assay; the sustained expression of the plasmid in vivo was determined by RT-PCR; the elevated uptake efficiency by phagocytes was observed with confocal microscopy; the biocompatibility was evaluated by cytotoxicity and histology assay; the complexes were administrated to C57BL/6 mice and the humoral and cellular immune responses were evaluated by ELISA, IFN-gamma production and cytolytic T lymphocyte (CTL)-specific lysis assay.Results The remaining relative activity of DNase I after inhibition varied from 32.3% to 77.6%. The Complexes were observed with higher uptake efficiency by phagocytes than naked DNA. Three types of nanoparticles did not induce significant cyLotoxicity at concentrations <= 400 mu g/ml. No specific histological alteration related to the injection of the complexes was observed. The formulations of DNA-nanoparticle complexes significantly enhanced the immunogenicity in several parameters: elevated antibody production, higher level of IFN-gamma secretion, and augmented specific cell lysis.Conclusions This study demonstrated the potential of the novel chitosan derivative nanoparticles for safe and effective DNA vaccine delivery. (c) Copyright 2007 John Wiley & Sons, Ltd.

A New Potent Route of DNA Vaccine Inoculation: DNA-Liposome Complexes on Bare Skin Induce Antigen-Special Antibody Responses

DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN

Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex.

DNA-based Vaccination Induces Humoral and Cellular Immune Responses Against Hepatitis B Virus Surface Antigen in Mice Without Activation of C-myc.

DNA-based Immunization Against Hepatitis B Surface Antigen Carrying Pres Epitopes

Microneedles Improve the Immunogenicity of DNA Vaccines.

Novel Chitosan Derivative Nanoparticles Enhance the Immunogenicity of a DNA Vaccine Encoding Hepatitis B Virus Core Antigen in Mice

Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model.

Intradermal naked plasmid DNA immunization: mechanisms of action

Successive Site Translocating Inoculation Potentiates DNA/recombinant Vaccinia Vaccination

Progress for Improving the Immune Response of DNA Vaccine

Application of in Vivo Electroporation Technology in Plasmid Mediated Gene Transfer and DNA Vaccination

Plasmid DNA Containing Multiple CpG Motifs Triggers a Strong Immune Response to Hepatitis B Surface Antigen when Combined with Incomplete Freund’s Adjuvant but Not Aluminum Hydroxide

Controlled Release of PEI/DNA Complexes from PLGA Microspheres As a Potent Delivery System to Enhance Immune Response to HIV Vaccine DNA Prime/mva Boost Regime.

DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response

Non-Methylated Cpg Motif Packaged into Fusogenic Liposomes Enhance Antigen-Specific Immunity in Mice

Humoral and cellular immunity to an encoded protein induced by direct DNA injection.

Targeting Hepatitis B Virus Antigens To Dendritic Cells By Heat Shock Protein To Improve Dna Vaccine Potency

Effect of Plasmid DNA on Immunogenicity of HBsAg–Anti-HBs Complex

DNA Immunization with Recombinant HCV E2 Expression Plasmids.